Challenges and Innovations in Long-Acting Ocular Drug Delivery Systems

Participate in this topic

Submit your idea

You will be redirected to our submission process.

Submit your manuscript summarySubmit your manuscript

About this Research Topic

Submission deadlines

  1. Manuscript Summary Submission Deadline 20 October 2025 | Manuscript Submission Deadline 7 February 2026

  2. This Research Topic is still accepting articles.

    1. Check author guidelines

Background

In this research topic we would like to address the question of what improvements are needed in the treatment of posterior eye disease. These improvements likely include safer and more efficacious therapeutics, changes that improve the patient experience through less invasive or less frequent dosing, while also decreasing the burden on the health care system that is associated with frequent intravitreal administration of large molecule drugs. A desired outcome of this research topic is that the collection of manuscripts will help influence future treatment paradigms for back of the eye diseases.

Treatments for posterior eye diseases, such as age-related macular degeneration (AMD), diabetic retinopathy (DR), and posterior uveitis, have seen significant advancements, particularly with the widespread use of intravitreal injections (e.g., anti-VEGF therapies for wet AMD and diabetic macular edema). Protein-based therapeutics such as aflibercept and ranibizumab have been critical components of wet AMD treatment. More recently, peptidic complement inhibitors administered via intravitreal injection have gained approval (US) for treatment of geographic atrophy (GA), an advanced form of dry AMD, and have shown modest therapeutic benefit. Substantial improvement in treatment options is necessary to enhance patient outcomes and quality of life. Less frequent intravitreal injections, or less invasive routes of administration, would increase availability of vision sparing treatments to new patients worldwide and enhance the treatment experience for existing patients. Improved gain in vision beyond what can be obtained with anti-VEGF alone in patients that respond to anti-VEGF therapy, and efficacy for patients that are non-responders to anti-VEGF, would have an impact on quality of life. More effective treatment options for GA, with better durability of effect than current approved therapeutics, likely would result in a greater sparing of vision for those suffering from this disease. Manuscripts that address these concepts, with scope as described below, are requested for consideration to be included in a research topic collection on treatment improvements for posterior eye disease to be published in Frontiers in Drug Delivery.

Current treatments often require frequent intravitreal injections, which can be burdensome, uncomfortable, and carry risks like infection, hemorrhage, and retinal detachment. Patient access to treatment has been limited since health care professionals (HCPs) trained in intravitreal injection are required to administer the drugs. Demand for anti-VEGF therapies has created logistical challenges for facilities with capabilities and staffing for performing intravitreal injections. Nucleic acid based medicines (NABM) have shown promise for durable treatment but efficacy in pivotal clinical trials has yet to be demonstrated. While anti-VEGF therapies have revolutionized treatment for neovascular conditions, many posterior eye diseases involve complex inflammatory, degenerative, or genetic pathways beyond VEGF such that different and/or additional drugs are required. Further research is needed to meet these challenges.

Here are key areas where advances are needed, and where submissions can shape future treatment paradigms for posterior eye diseases. Manuscripts describing original research, reviews, and commentaries are welcome:

• Drug Delivery Systems: There is a need for therapies with longer duration to reduce injection frequency, as well as alternative and less invasive delivery routes (e.g., sustained-release implants, topical or systemic administration). Novel approaches to overcome ocular barriers are encouraged.
• Treatment Efficacy: New drugs targeting pathways beyond anti-VEGF, combination therapies, and improved bioavailability are critical. Neuroprotective strategies and pre-clinical/clinical models that better predict human response are also sought.
• Early Detection: Enhanced diagnostic tools and personalized treatment strategies can enable earlier intervention, improving outcomes and minimizing side effects. Prophylactic treatments are also valuable.
• Safety: Safer therapies with fewer ocular and systemic side effects are essential, including better delivery methods and risk assessment.
• Regenerative Medicine and Gene Therapy: Advances in stem cell therapies, gene therapy, and gene editing (like CRISPR) hold promise for restoring vision, not just preserving it.

Future therapies will focus on being less invasive, more effective, and safer, with a strong emphasis on regeneration and disease modification.

Article types and fees

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

  • Brief Research Report
  • Case Report
  • Clinical Trial
  • Community Case Study
  • Data Report
  • Editorial
  • General Commentary
  • Hypothesis and Theory
  • Methods

Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.

Article types

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

  • Brief Research Report
  • Case Report
  • Clinical Trial
  • Community Case Study
  • Data Report
  • Editorial
  • General Commentary
  • Hypothesis and Theory
  • Methods
  • Mini Review
  • Opinion
  • Original Research
  • Perspective
  • Policy and Practice Reviews
  • Policy Brief
  • Review
  • Study Protocol
  • Systematic Review
  • Technology and Code

Keywords: Posterior Eye Disease, Retinal Disease, Posterior Uveitis, Intravitreal Injection, Non-invasive Delivery

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Topic editors

Topic coordinators

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

     

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

     

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.

     

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Submit your idea

You will be redirected to our submission process.

Submit your manuscript summarySubmit your manuscript

Share on WeChat

Scan with WeChat to share this article